Effect on diurnal intraocular pressure variation of eliminating the α-2 adrenergic receptor subtypes in the mouse

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 3, 2008, Pages 929-933

  Aihara, Makoto ^a,b   Lindsey, James D ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE; ADRENERGIC RECEPTOR ALPHA 2B; ADRENERGIC RECEPTOR ALPHA(2C); ADRENERGIC RECEPTOR ALPHA-2B; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; GENOTYPE; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; C57BL MOUSE; MOUSE MUTANT; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CIRCADIAN RHYTHM; GENOTYPE; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; TONOMETRY, OCULAR;

EID: 41949116895     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0386     Document Type: Article

References (28)

1. Serle J, Castelbuono A. Adrenergic agonists. In: Morrison J, Pollack I, eds. Glaucoma: Science and Practice. New York: Thieme; 2003: 363-373.
2. Kiuchi Y, Yoshitomi T, Gregory D. Do α-adrenergic receptors participate in control of the circadian rhythm of IOP? Invest Ophthalmol Vis Sci. 1992;33:3186-3194.
3. Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol. 2003;121:453-457.
4. Bylund D, Blaxall H, Iversen L, Caron M, Lefkowitz R, Lomasney J. Pharmacological characteristics of α2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol. 1992;42:1-5.
5. Philipp M, Brede M, Hein L. Physiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol. 2002;283:R287-R295.
6. MacDonald E, Kobilka BK, Scheinin M. Gene targeting: homing in on α2-adrenoceptor-subtype function. Trends Pharmacol Sci. 1997;18:211-219.
7. Link R, Daunt D, Barsh G, Chruscinski A, Kobilka B. Cloning of two mouse genes encoding α2-adrenergic receptor subtypes and identification of a single amino acid in the mouse α2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol. 1992;42:16 -27.
8. Cleary L, Vandeputte C, Docherty JR. Investigation of neurotransmission in vas deferens from α(2A/D)-adrenoceptor knockout mice. Br J Pharmacol. 2002;136:857-864.
9. Bylund DB. Pharmacological characteristics of α2 adrenergic receptor subtypes. Ann NY Acad Sci. 1995;763:1-7.
10. MacKinnon AC, Spedding M, Brown CM. α2-adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol Sci. 1994;15:119-123.
11. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE. Central hypotensive effects of the α2A-adrenergic receptor subtype. Science. 1996;273:801-803.
12. Link RE, Desai K, Hein L, et al. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes B and C. Science. 1996; 273:803-805.
13. Altman JD, Trendelenburg AU, MacMillan L, et al. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol. 1999;56:154-161.
14. Hein L. Transgenic models of α2-adrenergic receptor subtype function. Rev Physiol Biochem Pharmacol. 2001;142:161-185.
15. Bylund DB, Chacko DM. Characterization of α2 adrenergic receptor subtypes in human ocular tissue homogenates. Invest Ophthalmol Vis Sci. 1999;40:2299-2306.
16. Huang Y, Gil DW, Vanscheeuwijck P, Stamer WD, Regan JW. Localization of α2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Invest Ophthalmol Vis Sci. 1995;36:2729-2739.
17. Wikberg-Matsson A, Wikberg J, Uhlen S. Characterization of α2-adrenoceptor subtypes in the porcine eye: identification of α2Aadrenoceptors in the choroid, ciliary body and iris, and α2A- and α2C-adrenoceptors in the retina. Exp Eye Res. 1996;63:57-66.
18. Wikberg-Matsson A, Simonsen U. Potent α2A-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries. Invest Ophthalmol Vis Sci. 2001;42:2049-2055.
19. Smith R, Zabaleta A, Savinova O, John S. The mouse anterior chamber angle and trabecular meshwork develop without cell death. BMC Dev Biol. 2001;1:3.
20. Lindsey JD, Weinreb RN. Identification of the mouse uveoscleral outflow pathway using fluorescent dextran. Invest Ophthalmol Vis Sci. 2002;43:2201-2205.
21. Aihara M, Lindsey J, Weinreb R. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
22. Aihara M, Lindsey J, Weinreb R. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77:681-686.
23. McLaren JW, Brubaker RF, FitzSimon JS. Continuous measurement of intraocular pressure in rabbits by telemetry. Invest Ophthalmol Vis Sci. 1996;37:966-975.
24. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40:2912-2917.
25. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci. 1998;39:2707-2012.
26. Liu JH. Circadian rhythm of intraocular pressure. J Glaucoma. 1998;7:141-147.
27. Blondeau P, Tetrault JP, Papamarkakis C. Diurnal variation of episcleral venous pressure in healthy patients: a pilot study. J Glaucoma. 2001;10:18 -24.
28. Blaxall H, Hass N, Bylund D. Expression of α2-adrenergic receptor genes in rat tissues. Receptor. 1994;4:191-199.